The purpose of this study is to further characterize the treatment related changes in insulin sensitivity, substrate metabolism and intrahepatic-intramyocellular lipids in patients with growth hormone deficiency (GHD).
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
24
Dosage regulation will follow the local recommendations of GHD treatment
Medical department M (Endocrinology and Diabetes), Aarhus University Hospital, Aarhus Sygehus, Denmark.
Aarhus, Aarhus, Denmark
Medical Department M, Aarhus University Hospital
Aarhus, Denmark
insulin sensitivity
Time frame: before and after 3 months treatment with growth hormone
substrate metabolism
Time frame: before and after 3 months of growth hormone treatment
intrahepatic lipid content
Time frame: before and after 3 months of growth hormone treatment
intramyocellular lipid content
Time frame: before and after 3 months of growth hormone treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.